Pacak, K., Eisenhofer, G. & Tischler, A. S. Phaeochromocytoma-advances through science, collaboration and spreading the word. Nat. Rev. Endocrinol. 16, 621–622 (2020).
Tooker, E. L. et al. The natural history of observed SDHx-related head and neck paragangliomas using three-dimensional volumetric tumor analysis. Otol. Neurotol. 44, 931–940 (2023).
Jansen, T. T. G., Timmers, H. J. L. M., Marres, H. A. M. & Kunst, H. P. M. Feasibility of a wait-and-scan period as initial management strategy for head and neck paraganglioma. Head Neck 39, 2088–2094 (2017).
Richter, S. et al. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine. Endocr. Relat. Cancer 29, 213–224 (2022).
Article CAS PubMed PubMed Central Google Scholar
McCrary, H. C. et al. Characterization of malignant head and neck paragangliomas at a single institution across multiple decades. JAMA Otolaryngol. Head Neck Surg. 145, 641–646 (2019).
Article PubMed PubMed Central Google Scholar
Taïeb, D. et al. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. Lancet Diabetes Endocrinol. 11, 345–361 (2023).
Prasad, S. C. et al. The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas. Otol. Neurotol. 35, 922–931 (2014).
Lloyd, S., Obholzer, R. & Tysome, J. BSBS Consensus Group. British Skull Base Society clinical consensus document on management of head and neck paragangliomas. Otolaryngol. Head Neck Surg. 163, 400–409 (2020).
Sanna, M., Piazza, P., Shin, S.-H., Flanagan, S. & Mancini, F. Microsurgery of Skull Base Paraganglioma (Thieme, 2013).
Pamporaki, C. et al. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort. Lancet Digit. Health 5, e551–e559 (2023).
留言 (0)